Systemic administration of recombinant interferon alfa in carcinoma patients upregulates the expression of the carcinoma-associated antigens tumor-associated glycoprotein-72 and carcinoembryonic antigen

Journal of Clinical Oncology

Volumn 14, Issue 7, 1996, Pages 2031-2042

  Roselli, M ^a   Guadagni, F ^a   Buonomo, O ^a   Belardi, A ^a   Vittorini, V ^a   Mariani Costantini, R ^a   Greiner, J W ^a   Casciani, C U ^a   Schlom, J ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; RECOMBINANT ALPHA2A INTERFERON;

ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CLINICAL ARTICLE; DRUG EFFICACY; FEVER; GASTROINTESTINAL CARCINOMA; HUMAN; HUMAN TISSUE; INTRAMUSCULAR DRUG ADMINISTRATION; LEUKOPENIA; MYALGIA; PRIORITY JOURNAL; SERODIAGNOSIS;

EID: 0029948328     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.7.2031     Document Type: Article

References (46)

1. Bouroncle BA: Thirty-five years in the progress of hairy cell leukemia. Leuk Lymphoma 1:1-12, 1994
2. Borden EC: Innovative treatment strategies for non-Hodgkin's lymphoma and multiple myeloma. Semin Oncol 21:14-22, 1994 (suppl 14)
3. Buzaid AC, Legha SS: Combination of chemotherapy with interleukin-2 and interferon-α for the treatment of advanced melanoma. Semin Oncol 21:23-28, 1994 (suppl 14)
4. Basham TY, Bourgeade MF, Creasey AA, et al: Interferon increases HLA synthesis in melanoma cells: Interferon resistant and sensitive cell lines. Proc Natl Acad Sci USA 79:3265-3269, 1982
5. Gasti G, Mosth C, Leiter E, et al: Effects of human recombinant α2-arg-interferon and γ-interferon on human breast cancer cell lines: Dissociation of antiproliferative activity and induction of HLA-DR antigen expression. Cancer Res 45:2957-2961, 1985
6. Rosa FM, Fellous M: Regulation of HLA-DR gene by IFN-γ. Transcriptional and post-transcriptional control. J Immunol 140:1660-1664, 1988
7. Boyer CM, Dawson DV, Neal SE, et al: Differential induction by interferons of major histocompatibility complex-encoded and non-major histocompatibility-encoded antigens in human breast and ovarian carcinoma cell lines. Cancer Res 49:2928-2934, 1989
8. Attallah AM, Needy CF, Noguchi PD, et al: Enhancement of carcinoembryonic antigen expression by interferon. Int J Cancer 24:49-52, 1979
9. Greiner JW, Hand PH, Noguchi PD, et al: Enhanced expression of surface tumor-associated antigens on human breast and colon tumor cells after recombinant human leukocyte α-interferon treatment. Cancer Res 44:3208-3214, 1984
10. Greiner JW, Fischer PB, Pestka S, et al: Differential effects of recombinant human leukocyte interferons on cell surface antigen expression. Cancer Res 46:4984-4990, 1986
11. Guadagni F, Schlom J, Johnston WW, et al: Selective interferon-induced enhancement of tumor-associated antigens on a spectrum of freshly isolated human adenocarcinoma cells. J Natl Cancer Inst 81:502-512, 1989
12. Kantor J, Tran R, Greiner JW, et al: Modulation of carcinoembryonic antigen messenger RNA levels in human colon carcinoma cells by recombinant human γ-interferon. Cancer Res 49:2651-2655, 1989
13. Greiner JW, Guadagni F, Horan Hand P, et al: Augmentation of tumor antigen expression by recombinant human IFNs: enhanced targeting of monoclonal antibodies to carcinomas, in Goldenberg DM (ed): Cancer Imaging With Radiolabeled Antibodies. Norwell, MA, Nijhoff, 1990, pp 413-432
14. Guadagni F, Witt P, Robbins P, et al: Regulation of carcinoembryonic antigen expression in differential human colorectal tumors cells by interferon-γ. Cancer Res 50:6248-6255, 1990
15. Guadagni F, Kantor J, Schlom J et al: Regulation of tumor antigen expression by recombinant Interferons, in (Fisher PB (ed): Mechanisms of Differentiation, vol 2. Boca Raton, FL, CRC, 1990, pp 57-80
16. Hauck W, Stanners CP: Control of carcinoembryonic antigen gene family expression in a differentiating colon carcinoma cell line, Caco-2. Cancer Res 51:3526-3533, 1991
17. Colcher D, Horan Hand P, Nuti M, et al: A spectrum of monoclonal antibodies reactive with human mammary tumor cells. Proc Natl Acad Sci USA 78:3199-3203, 1981
18. Johnson VG, Schlom J, Paterson AJ, et al: Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3. Cancer Res 46:850-857, 1986
19. Thor A, Ohuchi N, Szpak CA, et al: Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3. Cancer Res 46:3118-3124, 1986
20. Thor A, Viglione MJ, Muraro R, et al: Monoclonal antibody B72.3 reactivity with human endometrium: A study of normal and malignant tissues. Int J Gynecol Pathol 6:235-247, 1987
21. Gold P, Freedman SO: Demonstration of tumor specific antigens in human colonic carcinoma by immunologic tolerance and absorption techniques. J Exp Med 121:439-445, 1965
22. Goldenberg DM, Sharkey RM, Primus FG: Carcinoembryonic antigen in histopathology: Immunoperoxidase staining of conventional tissue sections. J Natl Cancer Inst 57:11-22, 1976
23. Sikorska H, Shuster J, Gold P: Clinical applications of carcinoembryonic antigen. Cancer Detect Prev 12:321-355, 1988
24. Cournoyer D, Beauchemin N, Boucher D, et al: Transcription of genes of the carcinoembryonic antigen family in malignant and nonmalignant human tissues. Cancer Res 48:3153-3157, 1988
25. Greiner JW, Guadagni F, Noguchi P, et al: Recombinant interferon enhances monoclonal antibody targeting of carcinoma lesions in vivo. Science 26:895-899, 1987
26. Guadagni F, Schlom J, Pothen S, et al: Parameters involved in the enhancement of monoclonal antibody targeting in vivo with recombinant interferon. Cancer Immunol Immunother 26:222-230, 1988
27. Kuhn JA, Beatty BG, Wong JVC, et al: Interferon enhancement of radioimmunotherapy for colon carcinoma. Cancer Res 51:2335-2339, 1991
28. Greiner JW, Dansky Ullmann C, Nieroda C, et al: Improved immunotherapeutic efficacy of an anti-carcinoma monoclonal antibody (CC49) when given in combination with IFN-γ. Cancer Res 53:600-608, 1993
29. Nieroda CA, Milenic DE, Carrasquillo JA, et al: Improved tumor radioimmunodetection using a single-chain Fv and γ-interferon: Potential clinical applications for radioimmunoguided surgery and γ scanning. Cancer Res 55:2858-2865, 1995
30. Greiner JW, Guadagni F, Goldstein D, et al: IP administration of interferon-gamma to carcinoma patients enhances expression of tumor-associated glycoprotein-72 (TAG-72) and carcinoembryonic antigen (CEA) on malignant ascites cells. J Clin Oncol 10:735-746, 1991
31. Mahvi DM, Madsen JA, Witt PL, et al: Interferon α enhances expression of TAG-72 and carcinoembryonic antigen in patients with primary colorectal cancer. Cancer Immunol Immunother 40:311-314, 1995
32. 111Inlabeled antimelanoma antibody 96.5 in melanoma patients. J Natl Cancer Inst 80:160-165, 1988
33. Murray JL, Macey DJ, Rosenblum MG, et al: Enhanced TAG-72 expression and tumor uptake of radiolabeled monoclonal antibody in metastatic breast cancer patients following α-interferon treatment. Cancer Res 55:5925-5928, 1995 (suppl)
34. Goldenberg DM, Deland F, Kim E, et al: Use of radiolabeled monoclonal antibodies for the detection of human carcinomas by external photoscanning and tomoscintigraphy. N Engl J Med 298:1384-1388, 1978
35. Mach JP, Carrel S, Forni M, et al: Tumor localization of radiolabeled antibodies against carcinoembryonic antigen in patients with carcinoma. N Engl J Med 303:5-10, 1980
36. Schlom J: New approaches to improved antibody targeting. Antibody Immunoconj Radiopharm 4:819-828, 1991
37. Colcher D, Minelli MF, Roselli M, et al: Radioimmunolocalization of human carcinoma xenografts with B72.3 second generation monoclonal antibodies. Cancer Res 48:4597-4603, 1988
38. Muraro R, Kuroki M, Wunderlich D, et al: Generation and characterization of second generation (B72.3) monoclonal antibodies reactive with the TAG-72 antigen. Cancer Res 48:4588-4596, 1988
39. Muraro R, Wunderlich D, Thor A, et al: Definition of monoclonal antibodies of a repertoire of epitopes on carcinoembryonic antigen differentially expressed in human colon carcinoma versus normal adult tissues. Cancer Res 45:5769-5780, 1985
40. Kuroki M, Greiner JW, Simpson JF, et al: Serologic mapping and biochemical characterization of the carcinoembryonic antigen epitopes using fourteen distinct monoclonal antibodies. Int J Cancer 44:208-218, 1989
41. Hsu SM, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabelled antibody (PA) procedures. J Histochem Cytochem 29:577-580, 1981
42. Guadagni F, Roselli M, Cosimelli M, et al: TAG-72 (CA 72-4) assay as a complementary serum tumor antigen to CEA in monitoring patients with colorectal cancer. Cancer 72:2098-2106, 1993
43. Greiner JW, Guadagni F, Goldstein D, et al: Evidence for the elevation of serum carcinoembryonic antigen (CEA) and tumorassociated glycoprotein-72 (TAG-72) levels in patients administered interferon. Cancer Res 51:4155-4163, 1991
44. 111In-CYT-103). Antibody Immunoconj Radiopharm 2:257-269, 1989
45. Arnold M, Schneebaum S, Berens A, et al: Intraoperative detection of colorectal cancer with radioimmunoguided surgery and CC49, second generation monoclonal antibody. Ann Surg 216:627-632, 1992
46. Kantor J, Irvine K, Abrams S, et al: Antitumor activity and immune response induced by a recombinant carcinoembryonic antigen vaccinia virus vaccine. J Natl Cancer Inst 84:1084-1091, 1992